BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32216819)

  • 1. IGF-1C domain-modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI.
    Yao Y; Yang L; Feng LF; Yue ZW; Zhao NH; Li Z; He ZX
    Stem Cell Res Ther; 2020 Mar; 11(1):136. PubMed ID: 32216819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
    Zhao N; Yue Z; Cui J; Yao Y; Song X; Cui B; Qi X; Han Z; Han ZC; Guo Z; He ZX; Li Z
    Stem Cell Res Ther; 2019 Apr; 10(1):129. PubMed ID: 31036073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE
    Cao X; Duan L; Hou H; Liu Y; Chen S; Zhang S; Liu Y; Wang C; Qi X; Liu N; Han Z; Zhang D; Han ZC; Guo Z; Zhao Q; Li Z
    Theranostics; 2020; 10(17):7697-7709. PubMed ID: 32685014
    [No Abstract]   [Full Text] [Related]  

  • 4. A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia.
    Zhang K; Chen X; Li H; Feng G; Nie Y; Wei Y; Li N; Han Z; Han ZC; Kong D; Guo Z; Zhao Q; Li Z
    Acta Biomater; 2020 Sep; 113():289-304. PubMed ID: 32663662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.
    Wang H; Shang Y; Chen X; Wang Z; Zhu D; Liu Y; Zhang C; Chen P; Wu J; Wu L; Kong D; Yang Z; Li Z; Chen X
    Int J Nanomedicine; 2020; 15():4311-4324. PubMed ID: 32606679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
    Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
    Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ activated mesenchymal stem cells (MSCs) by bioactive hydrogels for myocardial infarction treatment.
    Gao L; Yi M; Xing M; Li H; Zhou Y; Xu Q; Zhang Z; Wen Z; Chang J
    J Mater Chem B; 2020 Sep; 8(34):7713-7722. PubMed ID: 32724972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.
    Feng G; Zhang J; Li Y; Nie Y; Zhu D; Wang R; Liu J; Gao J; Liu N; He N; Du W; Tao H; Che Y; Xu Y; Kong D; Zhao Q; Li Z
    J Am Soc Nephrol; 2016 Aug; 27(8):2357-69. PubMed ID: 26869006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan Hydrogel Enhances the Therapeutic Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells for Myocardial Infarction by Alleviating Vascular Endothelial Cell Pyroptosis.
    Liu Y; Li P; Qiao C; Wu T; Sun X; Wen M; Zhang W
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):75-83. PubMed ID: 31663873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic regenerative therapy of thin endometrium by human placenta-derived mesenchymal stem cells encapsulated within hyaluronic acid hydrogels.
    Lin Y; Dong S; Ye X; Liu J; Li J; Zhang Y; Tu M; Wang S; Ying Y; Chen R; Wang F; Ni F; Chen J; Du B; Zhang D
    Stem Cell Res Ther; 2022 Feb; 13(1):66. PubMed ID: 35135594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1C domain-modified chitosan hydrogel accelerates cutaneous wound healing by promoting angiogenesis.
    Li Q; Cui J; Huang H; Yue Z; Chang Y; Li N; Han Z; Han ZC; Guo Z; Li Z
    Future Med Chem; 2020 Jul; 12(13):1239-1251. PubMed ID: 32351127
    [No Abstract]   [Full Text] [Related]  

  • 16. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
    Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
    Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse opal substrate-loaded mesenchymal stem cells contribute to decreased myocardial remodeling after transplantation into acute myocardial infarction mice.
    Lu W; Ji J; Ma G; Dai Q; Chen L; Zuo P; Zhao Y
    Int J Nanomedicine; 2018; 13():7033-7046. PubMed ID: 30464457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
    Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
    Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.